vs
Side-by-side financial comparison of MARKETWISE, INC. (MKTW) and STEM, INC. (STEM). Click either name above to swap in a different company.
MARKETWISE, INC. is the larger business by last-quarter revenue ($83.4M vs $47.1M, roughly 1.8× STEM, INC.). MARKETWISE, INC. runs the higher net margin — 2.3% vs -33.9%, a 36.2% gap on every dollar of revenue. On growth, MARKETWISE, INC. posted the faster year-over-year revenue change (-14.4% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs -12.5%).
MarketWise Inc. is a leading provider of investment research, financial market data, and wealth management education solutions. It serves both retail and institutional investors across North America, Europe, and the Asia-Pacific region, offering actionable market insights, portfolio analysis tools, and specialized multi-asset research.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
MKTW vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.4M | $47.1M |
| Net Profit | $1.9M | $-16.0M |
| Gross Margin | 87.0% | 48.9% |
| Operating Margin | 15.8% | -17.7% |
| Net Margin | 2.3% | -33.9% |
| Revenue YoY | -14.4% | -15.6% |
| Net Profit YoY | -9.8% | 68.8% |
| EPS (diluted) | $0.79 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $83.4M | $47.1M | ||
| Q3 25 | $81.3M | $38.2M | ||
| Q2 25 | $80.0M | $38.4M | ||
| Q1 25 | $83.5M | $32.5M | ||
| Q4 24 | $97.5M | $55.8M | ||
| Q3 24 | $97.2M | $29.3M | ||
| Q2 24 | $105.0M | $34.0M | ||
| Q1 24 | $109.0M | $25.5M |
| Q4 25 | $1.9M | $-16.0M | ||
| Q3 25 | $1.5M | $-23.8M | ||
| Q2 25 | $1.3M | $202.5M | ||
| Q1 25 | $890.0K | $-25.0M | ||
| Q4 24 | $2.1M | $-51.1M | ||
| Q3 24 | $1.7M | $-148.3M | ||
| Q2 24 | $1.5M | $-582.3M | ||
| Q1 24 | $1.7M | $-72.3M |
| Q4 25 | 87.0% | 48.9% | ||
| Q3 25 | 87.0% | 35.5% | ||
| Q2 25 | 86.3% | 33.4% | ||
| Q1 25 | 85.7% | 32.4% | ||
| Q4 24 | 88.7% | -4.4% | ||
| Q3 24 | 86.7% | 21.2% | ||
| Q2 24 | 87.3% | 27.6% | ||
| Q1 24 | 87.7% | -95.0% |
| Q4 25 | 15.8% | -17.7% | ||
| Q3 25 | 21.9% | -33.6% | ||
| Q2 25 | 18.5% | -34.8% | ||
| Q1 25 | 20.1% | -65.0% | ||
| Q4 24 | 24.8% | -84.4% | ||
| Q3 24 | 22.5% | -493.2% | ||
| Q2 24 | 20.3% | -1705.5% | ||
| Q1 24 | 19.8% | -267.0% |
| Q4 25 | 2.3% | -33.9% | ||
| Q3 25 | 1.9% | -62.2% | ||
| Q2 25 | 1.6% | 527.8% | ||
| Q1 25 | 1.1% | -76.9% | ||
| Q4 24 | 2.2% | -91.6% | ||
| Q3 24 | 1.8% | -506.3% | ||
| Q2 24 | 1.5% | -1712.6% | ||
| Q1 24 | 1.5% | -283.9% |
| Q4 25 | $0.79 | $-4.40 | ||
| Q3 25 | $0.58 | $-2.84 | ||
| Q2 25 | $0.53 | $-1.79 | ||
| Q1 25 | $0.41 | $-0.15 | ||
| Q4 24 | $1.06 | $-15.29 | ||
| Q3 24 | $0.87 | $-18.24 | ||
| Q2 24 | $0.80 | $-71.81 | ||
| Q1 24 | $0.85 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $70.1M | $48.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-11.7M | $-249.4M |
| Total Assets | $218.4M | $308.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $70.1M | $48.9M | ||
| Q3 25 | $50.5M | $43.1M | ||
| Q2 25 | $69.1M | $40.8M | ||
| Q1 25 | $79.2M | $58.6M | ||
| Q4 24 | $97.9M | $56.3M | ||
| Q3 24 | $94.1M | $75.4M | ||
| Q2 24 | $109.3M | $89.6M | ||
| Q1 24 | $131.2M | $112.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $707.0K | — |
| Q4 25 | $-11.7M | $-249.4M | ||
| Q3 25 | $-14.5M | $-235.7M | ||
| Q2 25 | $-15.8M | $-214.1M | ||
| Q1 25 | $-15.8M | $-417.5M | ||
| Q4 24 | $-12.5M | $-398.4M | ||
| Q3 24 | $-19.5M | $-344.1M | ||
| Q2 24 | $-23.7M | $-203.2M | ||
| Q1 24 | $-9.4M | $371.6M |
| Q4 25 | $218.4M | $308.9M | ||
| Q3 25 | $201.7M | $362.6M | ||
| Q2 25 | $211.8M | $379.2M | ||
| Q1 25 | $239.6M | $405.1M | ||
| Q4 24 | $259.5M | $437.4M | ||
| Q3 24 | $278.4M | $537.8M | ||
| Q2 24 | $315.3M | $691.5M | ||
| Q1 24 | $359.3M | $1.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $46.0M | $8.2M |
| Free Cash FlowOCF − Capex | $45.6M | — |
| FCF MarginFCF / Revenue | 54.6% | — |
| Capex IntensityCapex / Revenue | 0.5% | — |
| Cash ConversionOCF / Net Profit | 23.84× | — |
| TTM Free Cash FlowTrailing 4 quarters | $67.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $46.0M | $8.2M | ||
| Q3 25 | $2.2M | $11.4M | ||
| Q2 25 | $17.8M | $-21.3M | ||
| Q1 25 | $1.7M | $8.5M | ||
| Q4 24 | $-22.1M | $-14.7M | ||
| Q3 24 | $-5.8M | $-9.4M | ||
| Q2 24 | $-3.8M | $-11.9M | ||
| Q1 24 | $-18.5M | $-621.0K |
| Q4 25 | $45.6M | — | ||
| Q3 25 | $2.2M | — | ||
| Q2 25 | $17.7M | — | ||
| Q1 25 | $1.7M | — | ||
| Q4 24 | $-22.3M | — | ||
| Q3 24 | $-5.9M | — | ||
| Q2 24 | $-3.8M | — | ||
| Q1 24 | — | — |
| Q4 25 | 54.6% | — | ||
| Q3 25 | 2.7% | — | ||
| Q2 25 | 22.2% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | -22.9% | — | ||
| Q3 24 | -6.0% | — | ||
| Q2 24 | -3.6% | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.5% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
| Q4 25 | 23.84× | — | ||
| Q3 25 | 1.44× | — | ||
| Q2 25 | 13.76× | -0.11× | ||
| Q1 25 | 1.95× | — | ||
| Q4 24 | -10.36× | — | ||
| Q3 24 | -3.39× | — | ||
| Q2 24 | -2.46× | — | ||
| Q1 24 | -11.17× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
